NEW YORK (GenomeWeb News) - Osmetech today said it plans to submit an assay to predict individual response to the blood-thinning drug warfarin to the US Food and Drug Administration sometime late in 2007.
 
The company said it plans to launch the warfarin test, which will run on its eSensor XT-8 molecular diagnostic platform, in the first half of 2008.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.